LungFit™
DevicePatients will receive inhalations of 150 ppm for 40 min 4 times a day, up to 7 days (maximum 28 treatments)
NCT Number: NCT04606407
The purpose of this multi center, open label, randomized, study is to obtain information on the safety and efficacy of 150 ppm Nitric Oxide given in addition to the standard of care of patients with viral pneumonia
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Shaare Zedek Medical Center, Jerusalem, Israel
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will receive inhalations of 150 ppm for 40 min 4 times a day, up to 7 days (maximum 28 treatments)
Time frame: 30 days
Clinical safety will be assessed by incidence of Serious Adverse Events (SAEs)
Time frame: Baseline to 30 days
Time to fever resolution
Time frame: Baseline to 30 days
Number of patients requiring admission to ICU
Time frame: Baseline to 30 days
Time until patient no longer requires supportive oxygen
Time frame: Baseline to 30 days
b.d. Stable room air saturation of 93% and above or returning to baseline saturation, whichever is lower
Beyond Air Inc.
Industry
Prospective, Open-label, Randomized, Multi-Center Study for Safety and Efficacy Evaluation of Inhaled Nitric Oxide (NO) Given Intermittently to Adults With Viral Pneumonia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04644302
COVID-19, Coronaviridae Infections
Hradec Králové, Třebeš, Czechia
View Trial DetailsNCT04385823
Coronaviridae Infections, Coronavirus Infections
Colombes, France
View Trial DetailsNCT06349707
Infections, Lung Diseases
Vandœuvre-lès-Nancy, France
View Trial DetailsNCT02152358
DNA Virus Infections, Herpes Simplex
Marseille, France
View Trial Details